TOKYO, April 23, 2014—Canon Inc. ("Canon"; Headquarters: Tokyo, Japan; Chairman, President and CEO: Fujio Mitarai) announced today that it has completed the acquisition of Molecular Imprints, Inc. ("MII"; Headquarters: Austin, Texas, U.S.A.; CEO: Mark Melliar-Smith). The two companies reached an agreement in February this year under which MII would become a wholly owned subsidiary of Canon. With the completion of the acquisition as planned on April 18, MII's company name has been changed to Canon Nanotechnologies, Inc.
By making MII a wholly owned subsidiary, Canon aims to realize an early market entry through the accelerated development of next-generation semiconductor lithography systems capable of achieving reduced process geometries, seeking to not only firmly establish the Company within the semiconductor lithography equipment sector, but also contribute to the revitalization and expansion of the electronics market.
